Tribbles 3: A novel regulator of TLR2-mediated signaling in response to Helicobacter pylori lipopolysaccharide

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2462-2471

  Smith, Sinéad M ^a   Moran, Anthony P ^b   Duggan, Shane P ^a   Ahmed, Salah E ^c   Mohamed, Abdelhafeez S ^c   Windle, Henry J ^a   O'Neill, Luke A ^a   Kelleher, Dermot P ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; BACTERIUM LIPOPOLYSACCHARIDE; CCAAT ENHANCER BINDING PROTEIN; CHEMOKINE; I KAPPA B ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 8; MYD88 ADAPTOR LIKE PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TRIBBLES 3 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH EPITHELIUM;

CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TUMOR; CHEMOKINES; COLORECTAL NEOPLASMS; DOWN-REGULATION; EPITHELIAL CELLS; HEK293 CELLS; HELICOBACTER PYLORI; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; UP-REGULATION;

EID: 79951816974     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000864     Document Type: Article

References (54)

1. Kusters, J. G., A. H. van Vliet, and E. J. Kuipers. 2006. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 19: 449-490.
2. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. 1994. Shistosomes, liver flukes and Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum. 61: 1-241.
3. Uno, K., K. Kato, T. Atsumi, T. Suzuki, J. Yoshitake, H. Morita, S. Ohara, Y. Kotake, T. Shimosegawa, and T. Yoshimura. 2007. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1004-G1012.
4. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
5. O'Neill, L. A. 2006. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18: 3-9.
6. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17: 1-14.
7. Chochi, K., T. Ichikura, M. Kinoshita, T. Majima, N. Shinomiya, H. Tsujimoto, T. Kawabata, H. Sugasawa, S. Ono, S. Seki, and H. Mochizuki. 2008. Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Clin. Cancer Res. 14: 2909-2917.
8. Ishihara, S., M. A. Rumi, Y. Kadowaki, C. F. Ortega-Cava, T. Yuki, N. Yoshino, Y. Miyaoka, H. Kazumori, N. Ishimura, Y. Amano, and Y. Kinoshita. 2004. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J. Immunol. 173: 1406-1416.
9. Mandell, L., A. P. Moran, A. Cocchiarella, J. Houghton, N. Taylor, J. G. Fox, T. C. Wang, and E. A. Kurt-Jones. 2004. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect. Immun. 72: 6446-6454.
10. Kawahara, T., S. Teshima, A. Oka, T. Sugiyama, K. Kishi, and K. Rokutan. 2001. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect. Immun. 69: 4382-4389.
11. Yokota, S., T. Ohnishi, M. Muroi, K. Tanamoto, N. Fujii, and K. Amano. 2007. Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol. Med. Microbiol. 51: 140-148.
12. Lepper, P. M., M. Triantafilou, C. Schumann, E. M. Schneider, and K. Triantafilou. 2005. Lipopolysaccharides from Helicobacter pylori can act as antagonists for Toll-like receptor 4. Cell. Microbiol. 7: 519-528.
13. Triantafilou, M., F. G. Gamper, P. M. Lepper, M. A. Mouratis, C. Schumann, E. Harokopakis, R. E. Schifferle, G. Hajishengallis, and K. Triantafilou. 2007. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell. Microbiol. 9: 2030-2039.
14. Smith, M. F., Jr., A. Mitchell, G. Li, S. Ding, A. M. Fitzmaurice, K. Ryan, S. Crowe, and J. B. Goldberg. 2003. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-κ B activation and chemokine expression by epithelial cells. J. Biol. Chem. 278: 32552-32560.
15. Wu, M., L. G. Xu, Z. Zhai, and H. B. Shu. 2003. SINK is a p65-interacting negative regulator of NF-kappaB-dependent transcription. J. Biol. Chem. 278: 27072-27079.
16. Moran, A. P., I. M. Helander, and T. U. Kosunen. 1992. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J. Bacteriol. 174: 1370-1377.
17. Moran, A. P., Y. A. Knirel, S. N. Senchenkova, G. Widmalm, S. O. Hynes, and P. E. Jansson. 2002. Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis(x) and Lewis(y) expression by H. Pylori lipopolysaccharides. J. Biol. Chem. 277: 5785-5795.
18. Pece, S., D. Fumarola, G. Giuliani, E. Jirillo, and A. P. Moran. 1995. Activity in the Limulus amebocyte lysate assay and induction of tumor necrosis factor-α by diverse Helicobacter pylori lipopolysaccharide preparations. Innate Imm. 2: 455-462.
19. Arenzana-Seisdedos, F., B. Fernandez, I. Dominguez, J. M. Jacqué, D. Thomas, M. T. Diaz-Meco, J. Moscat, and J. L. Virelizier. 1993. Phosphatidylcholine hydrolysis activates NF-κ B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes. J. Virol. 67: 6596-6604.
20. Imaizumi, Y., S. Sugita, K. Yamamoto, D. Imanishi, T. Kohno, M. Tomonaga, and T. Matsuyama. 2002. Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3 α/CCL20 gene transcription via the NF-κ B pathway. Int. Immunol. 14: 147-155.
21. Muzio, M., J. Ni, P. Feng, and V. M. Dixit. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278: 1612-1615.
22. Cooke, E. L., I. J. Uings, C. L. Xia, P. Woo, and K. P. Ray. 2001. Functional analysis of the interleukin-1-receptor-associated kinase (IRAK-1) in interleukin-1 beta-stimulated nuclear factor kappa B (NF-kappa B) pathway activation: IRAK-1 associates with the NF-kappa B essential modulator (NEMO) upon receptor stimulation. Biochem. J. 359: 403-410.
23. Ling, L., Z. Cao, and D. V. Goeddel. 1998. NF-kappaB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. USA 95: 3792-3797.
24. Liljeholm, S., K. Hughes, T. Grundström, and P. Brodin. 1998. NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells. J. Gen. Virol. 79: 2117-2125.
25. Sambrook, J., and D. W. Russell. 2001. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
26. Irizarry, R. A., B. M. Bolstad, F. Collin, L. M. Cope, B. Hobbs, and T. P. Speed. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31: e15.
27. Torok, A. M., A. H. Bouton, and J. B. Goldberg. 2005. Helicobacter pylori induces interleukin-8 secretion by Toll-like receptor 2- and Toll-like receptor 5-dependent and -independent pathways. Infect. Immun. 73: 1523-1531.
28. Moran, A. P., B. Lindner, and E. J. Walsh. 1997. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J. Bacteriol. 179: 6453-6463.
29. Viala, J., C. Chaput, I. G. Boneca, A. Cardona, S. E. Girardin, A. P. Moran, R. Athman, S. Mémet, M. R. Huerre, A. J. Coyle, et al. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5: 1166-1174.
30. Basu, S., S. K. Pathak, G. Chatterjee, S. Pathak, J. Basu, and M. Kundu. 2008. Helicobacter pylori protein HP0175 transactivates epidermal growth factor receptor through TLR4 in gastric epithelial cells. J. Biol. Chem. 283: 32369-32376.
31. Ding, S. Z., A. M. Torok, M. F. Smith, Jr., and J. B. Goldberg. 2005. Toll-like receptor 2-mediated gene expression in epithelial cells during Helicobacter pylori infection. Helicobacter 10: 193-204.
32. Bäckhed, F., B. Rokbi, E. Torstensson, Y. Zhao, C. Nilsson, D. Seguin, S. Normark, A. M. Buchan, and A. Richter-Dahlfors. 2003. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J. Infect. Dis. 187: 829-836.
33. Maeda, S., M. Akanuma, Y. Mitsuno, Y. Hirata, K. Ogura, H. Yoshida, Y. Shiratori, and M. Omata. 2001. Distinct mechanism of Helicobacter pylori-mediated NF-κ B activation between gastric cancer cells and monocytic cells. J. Biol. Chem. 276: 44856-44864.
34. Cario, E., D. Brown, M. McKee, K. Lynch-Devaney, G. Gerken, and D. K. Podolsky. 2002. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol. 160: 165-173.
35. Bach, S., A. Makristathis, M. Rotter, and A. M. Hirschl. 2002. Gene expression profiling in AGS cells stimulated with Helicobacter pylori isogenic strains (cagA positive or cagA negative). Infect. Immun. 70: 988-992.
36. Liu, Z. F., C. Y. Chen, W. Tang, J. Y. Zhang, Y. Q. Gong, and J. H. Jia. 2006. Gene-expression profiles in gastric epithelial cells stimulated with spiral and coccoid Helicobacter pylori. J. Med. Microbiol. 55: 1009-1015.
37. Guillemin, K., N. R. Salama, L. S. Tompkins, and S. Falkow. 2002. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA 99: 15136-15141.
38. Wen, S., C. P. Felley, H. Bouzourene, M. Reimers, P. Michetti, and Q. Pan-Hammarström. 2004. Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans. J. Immunol. 172: 2595-2606. (Pubitemid 38182411)
39. Galamb, O., B. Gyõrffy, F. Sipos, E. Dinya, T. Krenács, L. Berczi, D. Szõke, S. Spisák, N. Solymosi, A. M. Németh, et al. 2008. Helicobacter pylori and antrum erosion-specific gene expression patterns: the discriminative role of CXCL13 and VCAM1 transcripts. Helicobacter 13: 112-126. (Pubitemid 351347658)
40. Marcos, N. T., A. Magalhães, B. Ferreira, M. J. Oliveira, A. S. Carvalho, N. Mendes, T. Gilmartin, S. R. Head, C. Figueiredo, L. David, et al. 2008. Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x. J. Clin. Invest. 118: 2325-2336.
41. Kusugami, K., T. Ando, M. Ohsuga, A. Imada, M. Shinoda, T. Konagaya, K. Ina, N. Kasuga, A. Fukatsu, S. Ichiyama, et al. 1997. Mucosal chemokine activity in Helicobacter pylori infection. J. Clin. Gastroenterol. 25(Suppl. 1): S203-S210.
42. Yamaoka, Y., M. Kita, T. Kodama, N. Sawai, T. Tanahashi, K. Kashima, and J. Imanishi. 1998. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 42: 609-617. (Pubitemid 28261044)
43. Park, S. M., J. H. Kim, Y. H. Hong, H. R. Jung, J. Park, J. G. Kim, and B. C. Yoo. 2001. Expression of mucosal cyto-chemokine mRNAs in patients with Helicobacter pylori infection. Korean J. Intern. Med. 16: 230-235.
44. Suzuki, H., M. Mori, A. A. Sakaguchi, M. Suzuki, S. Miura, and H. Ishii. 1998. Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease. J. Gastroenterol. Hepatol. 13: 516-520.
45. Tomimori, K., E. Uema, H. Teruya, C. Ishikawa, T. Okudaira, M. Senba, K. Yamamoto, T. Matsuyama, F. Kinjo, J. Fujita, and N. Mori. 2007. Helicobacter pylori induces CCL20 expression. Infect. Immun. 75: 5223-5232.
46. Wu, Y. Y., H. F. Tsai, W. C. Lin, P. I. Hsu, C. T. Shun, M. S. Wu, and P. N. Hsu. 2007. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Infect. Immun. 75: 4357-4363.
47. Rzymski, T., A. Paantjens, J. Bod, and A. L. Harris. 2008. Multiple pathways are involved in the anoxia response of SKIP3 including HuR-regulated RNA stability, NF-kappaB and ATF4. Oncogene 27: 4532-4543.
48. Ohoka, N., S. Yoshii, T. Hattori, K. Onozaki, and H. Hayashi. 2005. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 24: 1243-1255. (Pubitemid 40516607)
49. Ord, D., and T. Ord. 2005. Characterization of human NIPK (TRB3, SKIP3) gene activation in stressful conditions. Biochem. Biophys. Res. Commun. 330: 210-218.
50. Obonyo, M., M. Sabet, S. P. Cole, J. Ebmeyer, S. Uematsu, S. Akira, and D. G. Guiney. 2007. Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect. Immun. 75: 2408-2414.
51. Geiser, T., B. Dewald, M. U. Ehrengruber, I. Clark-Lewis, and M. Baggiolini. 1993. The interleukin-8-related chemotactic cytokines GRO α, GRO β, and GRO γ activate human neutrophil and basophil leukocytes. J. Biol. Chem. 268: 15419-15424.
52. Brasier, A. R., D. Ron, J. E. Tate, and J. F. Habener. 1990. A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element. EMBO J. 9: 3933-3944.
53. Stein, B., P. C. Cogswell, and A. S. Baldwin, Jr. 1993. Functional and physical associations between NF-κ B and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13: 3964-3974.
54. Du, S., N. Hiramatsu, K. Hayakawa, A. Kasai, M. Okamura, T. Huang, J. Yao, M. Takeda, I. Araki, N. Sawada, et al. 2009. Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J. Immunol. 182: 7201-7211.